BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31066215)

  • 1. Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ.
    Porrett PM; Reese PP; Holzmayer V; Coller KE; Kuhns M; Van Deerlin VM; Gentile C; Smith JR; Sicilia A; Woodards A; McLean R; Abt P; Bloom RD; Reddy KR; Blumberg E; Cloherty G; Goldberg D
    Am J Transplant; 2019 Sep; 19(9):2525-2532. PubMed ID: 31066215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients.
    Agbim U; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Bhalla A; Podila PSB; Maliakkal B; Nair S; Eason JD; Molnar MZ
    Ren Fail; 2020 Nov; 42(1):767-775. PubMed ID: 32729359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of HCV Ab+/NAT- donors in HCV naïve renal transplant recipients to expand the kidney donor pool.
    Dao A; Cuffy M; Kaiser TE; Loethen A; Cafardi J; Luckett K; Rike AH; Cardi M; Alloway RR; Govil A; Diwan T; Sherman KE; Shah SA; Woodle ES
    Clin Transplant; 2019 Jul; 33(7):e13598. PubMed ID: 31104346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial.
    McLean RC; Reese PP; Acker M; Atluri P; Bermudez C; Goldberg LR; Abt PL; Blumberg EA; Van Deerlin VM; Reddy KR; Bloom RD; Hasz R; Suplee L; Sicilia A; Woodards A; Zahid MN; Bar KJ; Porrett P; Levine MH; Hornsby N; Gentile C; Smith J; Goldberg DS
    Am J Transplant; 2019 Sep; 19(9):2533-2542. PubMed ID: 30768838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study.
    Franco A; Moreso F; Merino E; Sancho A; Kanter J; Gimeno A; Balibrea N; Rodriguez M; Perez Contreras F
    Transpl Int; 2019 Jul; 32(7):710-716. PubMed ID: 30773693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: Single center experience.
    Molnar MZ; Nair S; Cseprekal O; Yazawa M; Talwar M; Balaraman V; Podila PSB; Mas V; Maluf D; Helmick RA; Campos L; Nezakatgoo N; Eymard C; Horton P; Verma R; Jenkins AH; Handley CR; Snyder HS; Cummings C; Agbim UA; Maliakkal B; Satapathy SK; Eason JD
    Am J Transplant; 2019 Nov; 19(11):3046-3057. PubMed ID: 31306549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of viral hepatitis in solid organ transplantation].
    Mikolašević I; Sladoje-Martinović B; Orlić L; Milić S; Lukenda V; Župan Ž; Štimac D; Rački S
    Acta Med Croatica; 2014 Apr; 68(2):151-9. PubMed ID: 26012153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.
    Sibulesky L; Kling CE; Blosser C; Johnson CK; Limaye AP; Bakthavatsalam R; Leca N; Perkins JD
    Am J Transplant; 2018 Oct; 18(10):2465-2472. PubMed ID: 29451354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting antivirals.
    La Hoz RM; Sandıkçı B; Ariyamuthu VK; Tanriover B
    Am J Transplant; 2019 Nov; 19(11):3058-3070. PubMed ID: 31207073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus).
    Natov SN
    Transpl Infect Dis; 2002 Sep; 4(3):124-31. PubMed ID: 12421456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serologic responses to hepatitis C virus in solid organ transplant recipients.
    Preiksaitis JK; Cockfield SM; Fenton JM; Burton NI; Chui LW
    Transplantation; 1997 Dec; 64(12):1775-80. PubMed ID: 9422419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
    Woolley AE; Singh SK; Goldberg HJ; Mallidi HR; Givertz MM; Mehra MR; Coppolino A; Kusztos AE; Johnson ME; Chen K; Haddad EA; Fanikos J; Harrington DP; Camp PC; Baden LR;
    N Engl J Med; 2019 Apr; 380(17):1606-1617. PubMed ID: 30946553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.
    Watson J; Mulvihill MS; Cox ML; Rich L; Wolfe CR; Gray A; Hartwig MG
    Clin Transplant; 2019 Mar; 33(3):e13476. PubMed ID: 30609162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of Hepatitis C Virus From Organ Donors Despite Nucleic Acid Test Screening.
    Suryaprasad A; Basavaraju SV; Hocevar SN; Theodoropoulos N; Zuckerman RA; Hayden T; Forbi JC; Pegues D; Levine M; Martin SI; Kuehnert MJ; Blumberg EA;
    Am J Transplant; 2015 Jul; 15(7):1827-35. PubMed ID: 25943299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus NAT-Positive Solid Organ Allografts Transplanted Into Hepatitis C Virus-Negative Recipients: A Real-World Experience.
    Kapila N; Menon KVN; Al-Khalloufi K; Vanatta JM; Murgas C; Reino D; Ebaid S; Shaw JJ; Agrawal N; Rhazouani S; Navas V; Sheffield C; Rahman AU; Castillo M; Lindenmeyer CC; Miller C; Quintini C; Zervos XB
    Hepatology; 2020 Jul; 72(1):32-41. PubMed ID: 31659775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac transplantation from non-viremic hepatitis C donors.
    Patel SR; Madan S; Saeed O; Sims DB; Shin JJ; Nucci C; Borukhov E; Goldstein DY; Jakobleff W; Forest S; Vukelic S; Murthy S; Reinus J; Puius Y; Goldstein DJ; Jorde UP
    J Heart Lung Transplant; 2018 Oct; 37(10):1254-1260. PubMed ID: 30126825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up.
    Wettersten N; Tran H; Mekeel K; Pretorius V; Adler E; Aslam S
    Transpl Infect Dis; 2019 Feb; 21(1):e13002. PubMed ID: 30222242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of hepatitis C virus infection among organ transplant recipients: implications for policies on organ procurement.
    Bouthot BA; Murthy BV; Schmid CH; Levey AS; Pereira BJ
    Transplantation; 1997 Mar; 63(6):849-53. PubMed ID: 9089225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.